跳至主要内容
临床试验/NCT03876704
NCT03876704Unknown3 期

Effects of Fat-soluble Vitamins Supplementation in Early Life on Common Complications and Neural Development in Very Low Birth Weight Infants

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年1月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
120
试验地点
1
主要终点
Vitamin levels

研究概览

简要总结

Vitamins A, D, and E play important roles in humans, such as vision function, immune function, bone metabolism, cell growth and differentiation and oxidation resistance. Deficiencies in these vitamins will result in a high prevalence of cardiovascular disease, infection, bone diseases, etc. Preterm infants, especially very low birth weight infants, are at risk of vitamin deficiency. Intravenous perfusion is the most common and widely used method to supply vitamins for the specific population in early life. However, the current dose of vitamin supplied by intravenous perfusion whether can meet the need of growth and development is not sure and the appropriate dose for preterm infants is still uncertain. The purpose of this study is to investigate whether current dose of fat-soluble vitamin supplementation is enough for very low birth weight infants, the safety of high dose of fat-soluble vitamin supplementation, and compare the differences of prevalence of common complications, such as bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia, and neural development between these two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
— 至 24 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • admitted to the neonatal intensive care unit (NICU) within 24 hours after birth
  • gestational age younger than 34 weeks
  • birth weight less than 1500 gram
  • informed consent was obtained from the infants' parents or guardians

排除标准

  • congenital malformation
  • chromosomal disease, genetic metabolic diseases
  • the infants or his/mother has abnormal thyroid function or parathyroid gland function
  • neonatal necrotizing enterocolitis, diarrhea
  • intracranial hemorrhage of 3 degrees or above
  • pulmonary hemorrhage
  • liver enzymes elevated by more than 2 times, cholestasis
  • death or discharge against medical advice
  • refuse to take part in the study

研究组 & 干预措施

High dose of fat-soluble vitamins

Experimental

Fat-soluble vitamins is administered 0.5 piece/kg (equals to 1150 U/kg vitamin A,200 U/kg vitamin D, 3.2 U/kg vitamin E) intravenously every day until the baby achieve full enteral feeding (120 ml/kg), starting with the first dose within 24 hours after birth.

干预措施: High dose of fat-Soluble Vitamin (Drug)

Conventional dose of fat-soluble vitamins

Active Comparator

Fat-soluble vitamins is administered 0.1 piece/kg (equals to 230 U/kg vitamin A,40 U/kg vitamin D, 0.64 U/kg vitamin E) intravenously every day until the baby achieve full enteral feeding (120 ml/kg), starting with the first dose within 24 hours after birth.

干预措施: Conventional dose of fat-Soluble Vitamin (Drug)

结局指标

主要结局

Vitamin levels

时间窗: within 72 hours after birth, 4~6 weeks old

Change from baseline level of vitamin A, vitamin D, and vitamin E at 4\~6 weeks

次要结局

  • Complications(corrected age of 36 weeks)
  • Neural development(corrected age of 40 weeks)
  • Gene polymorphism in vitamin deficiency preterm infants(within 72 hours after birth, 4~6 weeks old)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验